2020 annual financial data
Aytu BioPharma 2020 Net margin
Direct answer
Net margin was -49.29%.
Operating income was -21,131,000 USD and net income was -13,621,000 USD.
Operating cash flow was -28,373,887 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,632,000 USD
- Operating income
- -21,131,000 USD
- Net income
- -13,621,000 USD
- Operating cash flow
- -28,373,887 USD